Kyriaki Boki

2.2k total citations
54 papers, 1.2k citations indexed

About

Kyriaki Boki is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kyriaki Boki has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Rheumatology, 15 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kyriaki Boki's work include Systemic Lupus Erythematosus Research (20 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Vasculitis and related conditions (9 papers). Kyriaki Boki is often cited by papers focused on Systemic Lupus Erythematosus Research (20 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Vasculitis and related conditions (9 papers). Kyriaki Boki collaborates with scholars based in Greece, United States and United Kingdom. Kyriaki Boki's co-authors include Haralampos Μ. Moutsopoulos, John P. A. Ioannidis, Fotini N. Skopouli, Alexandros A. Drosos, H M Moutsopoulos, Athanasios G. Tzioufas, John Boletis, George E. Tzelepis, Alexandros A. Drosos and Jerry S. Lanchbury and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and The American Journal of Medicine.

In The Last Decade

Kyriaki Boki

49 papers receiving 1.2k citations

Peers

Kyriaki Boki
Kyriaki Boki
Citations per year, relative to Kyriaki Boki Kyriaki Boki (= 1×) peers Micol Frassi

Countries citing papers authored by Kyriaki Boki

Since Specialization
Citations

This map shows the geographic impact of Kyriaki Boki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyriaki Boki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyriaki Boki more than expected).

Fields of papers citing papers by Kyriaki Boki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyriaki Boki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyriaki Boki. The network helps show where Kyriaki Boki may publish in the future.

Co-authorship network of co-authors of Kyriaki Boki

This figure shows the co-authorship network connecting the top 25 collaborators of Kyriaki Boki. A scholar is included among the top collaborators of Kyriaki Boki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyriaki Boki. Kyriaki Boki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Κonstantinos, Emilia Hadziyannis, Kyriaki Boki, et al.. (2021). Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients. Arthritis Research & Therapy. 23(1). 90–90. 10 indexed citations
2.
Mavragani, Clio P., Kyriaki Boki, Athanasios G. Tzioufas, et al.. (2021). COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review. Journal of Autoimmunity. 123. 102687–102687. 18 indexed citations
3.
Panopoulos, Stylianos, Κonstantinos Thomas, Georgios Georgiopoulos, et al.. (2020). Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study. Lara D. Veeken. 60(1). 170–178. 26 indexed citations
4.
Plexousakis, Dimitris, Kostas Marias, Kyriaki Boki, et al.. (2020). Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group. Arthritis Research & Therapy. 22(1). 226–226. 10 indexed citations
5.
Mavrogeni, Sophie, George D. Kitas, Hildo J. Lamb, et al.. (2018). Combined brain and heart magnetic resonance imaging in systemic vasculitides: fiction or real need?. PubMed. 36 Suppl 111(2). 152–159. 5 indexed citations
6.
Boki, Kyriaki, et al.. (2018). Five-year prospective multi-center cohort study of patients with giant cell arteritis in Greece. Mediterranean Journal of Rheumatology. 29(2). 103–105.
7.
Vassilopoulos, Dimitrios, Loukas Settas, A. Andrianakos, et al.. (2017). Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study.. PubMed. 34(5). 893–900. 21 indexed citations
8.
Boubouchairopoulou, N., Alexandros A. Drosos, Kyriaki Boki, et al.. (2017). Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status.. PubMed. 34(6). 999–1005. 7 indexed citations
9.
Thomas, Κonstantinos, Petros P. Sfikakis, Dimitrios T. Boumpas, Kyriaki Boki, & Dimitrios Vassilopoulos. (2017). Study of the natural course and specific immunity after herpes zoster in patients with rheumatoid arthritis receiving biologic DMARDs. Mediterranean Journal of Rheumatology. 28(3). 164–168. 1 indexed citations
10.
Papanikolaou, Ιlias, Kyriaki Boki, Evangelos J. Giamarellos‐Bourboulis, et al.. (2014). Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases. Immunology Letters. 163(2). 179–186. 15 indexed citations
11.
Drosos, Alexandros A., Kyriaki Boki, Fotini N. Skopouli, et al.. (2009). Geriatric rheumatoid arthritis patients on delayed anti-TF-alpha agents have higher disease activity and experience more often serious adverse events compared to younger adults. Lund University Publications (Lund University). 1 indexed citations
12.
Sidiropoulos, Prodromos, Alexandros A. Drosos, Kyriaki Boki, et al.. (2009). Long-term follow-up of RA patients of the Hellenic Biologics Registry: comparison of first versus second anti-TNF-alpha therapy. Clinical and Experimental Rheumatology. 27(5). 708–708. 1 indexed citations
13.
Moyssakis, Ioannis, Elias Gialafos, Kyriaki Boki, et al.. (2009). Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scandinavian Journal of Rheumatology. 38(3). 216–221. 47 indexed citations
14.
Tzelepis, George E., Maria Kokosi, Athanasios G. Tzioufas, et al.. (2009). Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. European Respiratory Journal. 36(1). 116–121. 117 indexed citations
15.
Karassa, Fotini B., John P. A. Ioannidis, Kyriaki Boki, et al.. (2000). Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. The American Journal of Medicine. 109(8). 628–634. 71 indexed citations
16.
Ioannidis, John P. A., et al.. (2000). Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Kidney International. 57(1). 258–264. 177 indexed citations
17.
Boki, Kyriaki, et al.. (1997). HLA Phenotypes in Healthy Aged Subjects. Gerontology. 43(3). 176–181. 20 indexed citations
18.
Hatzis, G., K. Aroni, Alexis Kelekis, & Kyriaki Boki. (1996). Giant cell arteritis presenting as pulseless disease of the upper extremities. Clinical Rheumatology. 15(1). 88–90. 4 indexed citations
19.
Vaughan, Robert W., et al.. (1995). AN ANALYSIS OF HLA CLASS II GENE POLYMORPHISM IN BRITISH AND GREEK IDIOPATHIC MEMBRANOUS NEPHROPATHY PATIENTS. International Journal of Immunogenetics. 22(2). 179–186. 19 indexed citations
20.
Boki, Kyriaki & Spyridon P. Dourakis. (1995). Polymyositis associated with primary biliary cirrhosis. Clinical Rheumatology. 14(3). 375–378. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026